BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totaling 60,925 shares, a decline of 42.0% from the July 15th total of 105,031 shares. Based on an average daily volume of 120,769 shares, the short-interest ratio is presently 0.5 days.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. CWM LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 25.6% during the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock worth $50,000 after purchasing an additional 680 shares during the period. Steward Partners Investment Advisory LLC lifted its position in BlackRock Health Sciences Term Trust by 4.9% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 14,687 shares of the company’s stock worth $221,000 after purchasing an additional 688 shares during the period. Private Advisor Group LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 3.5% during the 3rd quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock worth $404,000 after acquiring an additional 940 shares in the last quarter. PMG Family Office LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 4.9% in the 1st quarter. PMG Family Office LLC now owns 28,227 shares of the company’s stock valued at $405,000 after purchasing an additional 1,320 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at about $26,000.
BlackRock Health Sciences Term Trust Trading Up 4.1%
NYSE:BMEZ traded up $0.68 during trading hours on Wednesday, reaching $16.96. 98,832 shares of the stock were exchanged, compared to its average volume of 214,418. The firm has a 50 day moving average of $15.34 and a 200 day moving average of $14.77. BlackRock Health Sciences Term Trust has a twelve month low of $13.70 and a twelve month high of $17.19.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Quantum Stocks Are Starting to Choose Sides: Should Investors Do the Same?
- AeroVironment Hit a Bottom in Q2—Can It Take Flight in Q3?
- The Pre-IPO Playbook: How to Cash in on Anthropic Before the Bell
- Tesla’s Cybercab Launch Could Reshape Margins for Uber and Lyft
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
